Alembic Pharma reports Q1 FY27 financial results
Alembic Pharma reports Q1 FY27 financial results. The company has announced its financial results for the quarter ended June 30, 2026. Key metrics include revenue of ₹1,240 crore and net profit of ₹182 crore, showing a 12% YoY decline in profitability due to higher R&D expenses.
📊 STOCKS: ALPHARM | 🏢 SECTOR: Pharma | #HIGHIMPACT #Earnings
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.